Drug Type Small molecule drug |
Synonyms 9-vinyl derivative 19(Acenta Discovery, Inc.) |
Target |
Action agonists |
Mechanism nAChRα4&β2 agonists(Neuronal acetylcholine receptor; alpha4/beta2 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC13H16N2O |
InChIKeyVHMDFCVLQUZHMQ-UHFFFAOYSA-N |
CAS Registry207391-24-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Smoking Cessation | Preclinical | United States | 04 May 2006 |